Higher set point plasma viral load and more-severe acute HIV type 1 (HIV-1) illness predict mortality among high-risk HIV-1-infected African women

被引:125
作者
Lavreys, L
Baeten, JM
Chohan, V
McClelland, RS
Hassan, WM
Richardson, BA
Mandaliya, K
Ndinya-Achola, JO
Overbaugh, J
机构
[1] Univ Washington, Dept Epidemiol, Seattle, WA 98104 USA
[2] Univ Washington, Dept Med, Seattle, WA 98104 USA
[3] Univ Washington, Dept Biostat, Seattle, WA 98104 USA
[4] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA
[5] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98104 USA
[6] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya
[7] Coast Gen Prov Hosp, Mombasa, Kenya
关键词
D O I
10.1086/503258
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. There is limited information on the natural history of human immunodeficiency virus type 1 (HIV-1) infection in Africa, especially from individuals with well-defined dates of infection. We used data from a prospective cohort study of female sex workers in Mombasa, Kenya, who were followed up monthly from before the date of HIV-1 infection. Methods. Antiretroviral-naive women who had a well-defined date of HIV-1 infection were included in this analysis. The effects of set point plasma viral load ( measured 4-24 months after infection), early CD4(+) cell count, and symptoms of acute HIV-1 infection on mortality were assessed using Cox proportional hazards analysis. Results. Among 218 women, the median duration of follow-up after HIV-1 infection was 4.6 years. Forty women died, and at 8.7 years ( the time of the last death), the cumulative survival rate was 51% by Kaplan-Meier analysis. Higher set point viral load, lower early CD4(+) cell count, and more-symptomatic acute HIV-1 illness each predicted death. In multivariate analysis, set point viral load ( hazard ratio [HR], 2.28 per 1 log 10 copies/mL increase; P = .001) and acute HIV-1 illness ( HR, 1.14 per each additional symptom; P = .05) were independently associated with higher mortality. Conclusion. Among this group of African women, the survival rate was similar to that for HIV-1-infected individuals in industrialized nations before the introduction of combination antiretroviral therapy. Higher set point viral load and more-severe acute HIV-1 illness predicted faster progression to death. Early identification of individuals at risk for rapid disease progression may allow closer clinical monitoring, including timely initiation of antiretroviral treatment.
引用
收藏
页码:1333 / 1339
页数:7
相关论文
共 42 条
[1]   Plasma viral load, CD4 cell percentage, HLA and survival of HIV-1, HIV-2, and dually infected Gambian patients [J].
Alabi, AS ;
Jaffar, S ;
Ariyoshi, K ;
Blanchard, T ;
van der Loeff, MS ;
Awasana, AA ;
Corrah, T ;
Sabally, S ;
Sarge-Njie, R ;
Cham-Jallow, F ;
Jaye, A ;
Berry, N ;
Whittle, H .
AIDS, 2003, 17 (10) :1513-1520
[2]   The relative value of CD4 cell count and quantitative HIV-1 RNA in predicting survival in HIV-1-infected women: results of the women's interagency HIV study [J].
Anastos, K ;
Kalish, LA ;
Hessol, N ;
Weiser, B ;
Melnick, S ;
Burns, D ;
Delapenha, R ;
DeHovitz, J ;
Cohen, M ;
Meyer, W ;
Bremer, J ;
Kovacs, A .
AIDS, 1999, 13 (13) :1717-1726
[3]   Acute sexually transmitted infections increase human immunodeficiency virus type 1 plasma viremia, increase plasma type 2 cytokines, and decrease CD4 cell counts [J].
Anzala, AO ;
Simonsen, JN ;
Kimani, J ;
Ball, TB ;
Nagelkerke, NJD ;
Rutherford, J ;
Ngugi, EN ;
Bwayo, JJ ;
Plummer, FA .
JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (02) :459-466
[4]   RAPID PROGRESSION TO DISEASE IN AFRICAN SEX WORKERS WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION [J].
ANZALA, OA ;
NAGELKERKE, NJD ;
BWAYO, JJ ;
HOLTON, D ;
MOSES, S ;
NGUGI, EN ;
NDINYAACHOLA, JO ;
PLUMMER, FA .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (03) :686-689
[5]  
Babiker A, 2000, LANCET, V355, P1131, DOI 10.1016/S0140-6736(00)02061-4
[6]   Broad spectrum of coreceptor usage and rapid disease progression in HIV-1-infected individuals from Central African Republic [J].
Bégaud, E ;
Feindirongai, G ;
Versmisse, P ;
Ipero, J ;
Léal, J ;
Germani, Y ;
Morvan, J ;
Fleury, H ;
Müller-Trutwin, M ;
Barré-Sinousi, F ;
Pancino, G .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2003, 19 (07) :551-560
[7]   TIME-COURSE OF DETECTION OF VIRAL AND SEROLOGIC MARKERS PRECEDING HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SEROCONVERSION - IMPLICATIONS FOR SCREENING OF BLOOD AND TISSUE DONORS [J].
BUSCH, MP ;
LEE, LLL ;
SATTEN, GA ;
HENRARD, DR ;
FARZADEGAN, H ;
NELSON, KE ;
READ, S ;
DODD, RY ;
PETERSEN, LR .
TRANSFUSION, 1995, 35 (02) :91-97
[8]   Long-term follow-up of HIV-positive and HIV-negative individuals in rural Malawi [J].
Crampin, AC ;
Floyd, S ;
Glynn, JR ;
Sibande, F ;
Mulawa, D ;
Nyondo, A ;
Broadbent, P ;
Bliss, L ;
Ngwira, B ;
Fine, PEM .
AIDS, 2002, 16 (11) :1545-1550
[9]   Gender difference in HIV-1 RNA viral loads [J].
Donnelly, CA ;
Bartley, LM ;
Ghani, AC ;
Le Fevre, AM ;
Kwong, GP ;
Cowling, BJ ;
van Sighem, AL ;
de Wolf, F ;
Rode, RA ;
Anderson, RM .
HIV MEDICINE, 2005, 6 (03) :170-178
[10]   Evaluation of performance of the Gen-Probe human immunodeficiency virus type 1 viral load assay using primary subtype A, C, and D isolates from Kenya [J].
Emery, S ;
Bodrug, S ;
Richardson, BA ;
Giachetti, C ;
Bott, MA ;
Panteleeff, D ;
Jagodzinski, LL ;
Michael, NL ;
Nduati, R ;
Bwayo, J ;
Kreiss, JK ;
Overbaugh, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (07) :2688-2695